12/01/2026
Robotic partial nephrectomy represents a significant advance in modern kidney cancer surgery, allowing precise removal of the tumour while preserving healthy kidney tissue, without compromising oncological outcomes. With enhanced 3-D visualisation, superior instrument control, and meticulous reconstruction, the robotic approach enables nephron-sparing surgery in appropriately selected patients, often resulting in reduced blood loss, less postoperative pain, shorter hospital stay, and faster functional recovery. This approach is now considered the standard of care for many small and moderate-sized renal tumours.
If you or someone in your family has been diagnosed with a kidney tumour, seeking a specialist second opinion is essential to evaluate the feasibility of a kidney-preserving robotic approach. Dr. Anshuman Singh is a fellowship-trained Urologist with an exclusive clinical focus on the management of urological cancers, including kidney, prostate, and bladder cancers. He has advanced expertise in robotic surgery for urological cancers and is committed to delivering evidence-based, organ-preserving cancer care. Currently serving as Vice-Chairperson – Uro-Oncology & Robotic Surgery at Chandan Cancer Institute, Lucknow, his practice emphasizes oncological safety, functional preservation, and individualized patient-centric decision-making through a multidisciplinary framework.
📍 Consultation: Uro-Oncology OPD, Chandan Cancer Institute, Chandan Hospital, Ayodhya Road, Lucknow
📞 Appointments: +91-8004959793 / 0522-6666666
🌐 Website: www.dranshumansingh.com
Early evaluation and the right surgical approach can make a meaningful difference in long-term outcomes.